These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 23164660

  • 1. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.
    Marhadour S, Marchand P, Pagniez F, Bazin MA, Picot C, Lozach O, Ruchaud S, Antoine M, Meijer L, Rachidi N, Le Pape P.
    Eur J Med Chem; 2012 Dec; 58():543-56. PubMed ID: 23164660
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.
    Marchand P, Bazin MA, Pagniez F, Rivière G, Bodero L, Marhadour S, Nourrisson MR, Picot C, Ruchaud S, Bach S, Baratte B, Sauvain M, Pareja DC, Vaisberg AJ, Le Pape P.
    Eur J Med Chem; 2015 Oct 20; 103():381-95. PubMed ID: 26383125
    [Abstract] [Full Text] [Related]

  • 3. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.
    Tahghighi A, Emami S, Razmi S, Rezazade Marznaki F, Kabudanian Ardestani S, Dastmalchi S, Kobarfard F, Shafiee A, Foroumadi A.
    J Enzyme Inhib Med Chem; 2013 Aug 20; 28(4):843-52. PubMed ID: 22651800
    [Abstract] [Full Text] [Related]

  • 4. Chemoenzymatic synthesis and biological evaluation of 2- and 3-hydroxypyridine derivatives against Leishmania mexicana.
    García Liñares G, Parraud G, Labriola C, Baldessari A.
    Bioorg Med Chem; 2012 Aug 01; 20(15):4614-24. PubMed ID: 22781310
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
    Istanbullu H, Bayraktar G, Akbaba H, Cavus I, Coban G, Debelec Butuner B, Kilimcioglu AA, Ozbilgin A, Alptuzun V, Erciyas E.
    Arch Pharm (Weinheim); 2020 Aug 01; 353(8):e1900325. PubMed ID: 32484266
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q, Cao J, Zhou X, Lv D, He Q, Yang B, Hu Y.
    Bioorg Med Chem; 2009 Jul 01; 17(13):4763-72. PubMed ID: 19447039
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y, Xin BT, Zhang Y, Wu J, Lu X, Zheng Y, Tang W, Zhou X.
    Eur J Med Chem; 2015 Jan 27; 90():170-83. PubMed ID: 25461318
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
    Khan I, Zaib S, Ibrar A, Rama NH, Simpson J, Iqbal J.
    Eur J Med Chem; 2014 May 06; 78():167-77. PubMed ID: 24681981
    [Abstract] [Full Text] [Related]

  • 9. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
    Sirajuddin M, McKee V, Tariq M, Ali S.
    Eur J Med Chem; 2018 Jan 01; 143():1903-1918. PubMed ID: 29133050
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents.
    Insuasty B, Montoya A, Becerra D, Quiroga J, Abonia R, Robledo S, Vélez ID, Upegui Y, Nogueras M, Cobo J.
    Eur J Med Chem; 2013 Sep 01; 67():252-62. PubMed ID: 23871905
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors.
    N'gompaza-Diarra J, Bettayeb K, Gresh N, Meijer L, Oumata N.
    Eur J Med Chem; 2012 Oct 01; 56():210-6. PubMed ID: 22982525
    [Abstract] [Full Text] [Related]

  • 12. Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors.
    Sato Y, Onozaki Y, Sugimoto T, Kurihara H, Kamijo K, Kadowaki C, Tsujino T, Watanabe A, Otsuki S, Mitsuya M, Iida M, Haze K, Machida T, Nakatsuru Y, Komatani H, Kotani H, Iwasawa Y.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4673-8. PubMed ID: 19589677
    [Abstract] [Full Text] [Related]

  • 13. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors.
    Zhang D, Ai J, Liang Z, Li C, Peng X, Ji Y, Jiang H, Geng M, Luo C, Liu H.
    Bioorg Med Chem; 2012 Sep 01; 20(17):5169-80. PubMed ID: 22863529
    [Abstract] [Full Text] [Related]

  • 14. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
    Queiroz MJ, Calhelha RC, Vale-Silva LA, Pinto E, São-José Nascimento M.
    Eur J Med Chem; 2010 Dec 01; 45(12):5732-8. PubMed ID: 20934235
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents.
    Lin R, Connolly PJ, Lu Y, Chiu G, Li S, Yu Y, Huang S, Li X, Emanuel SL, Middleton SA, Gruninger RH, Adams M, Fuentes-Pesquera AR, Greenberger LM.
    Bioorg Med Chem Lett; 2007 Aug 01; 17(15):4297-302. PubMed ID: 17532631
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
    Mohsin NU, Seebacher W, Faist J, Hochegger P, Kaiser M, Mäser P, Belaj F, Saf R, Kretschmer N, Alajlani M, Turek I, Brantner A, Bauer R, Bucar F, Weis R.
    Eur J Med Chem; 2018 Jan 01; 143():97-106. PubMed ID: 29172086
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors.
    Zhan W, Li Y, Huang W, Zhao Y, Yao Z, Yu S, Yuan S, Jiang F, Yao S, Li S.
    Bioorg Med Chem; 2012 Jul 15; 20(14):4323-9. PubMed ID: 22721924
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.
    Jacquemard U, Dias N, Lansiaux A, Bailly C, Logé C, Robert JM, Lozach O, Meijer L, Mérour JY, Routier S.
    Bioorg Med Chem; 2008 May 01; 16(9):4932-53. PubMed ID: 18439832
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK, Mittal M, Shivahare R, Gupta S, Bhandari K.
    Eur J Med Chem; 2011 May 01; 46(5):1694-700. PubMed ID: 21385661
    [Abstract] [Full Text] [Related]

  • 20. Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.
    Terao Y, Suzuki H, Yoshikawa M, Yashiro H, Takekawa S, Fujitani Y, Okada K, Inoue Y, Yamamoto Y, Nakagawa H, Yao S, Kawamoto T, Uchikawa O.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7326-9. PubMed ID: 23147077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.